Medicine
Doxorubicin 20 mg/10 mL liposomal injectable suspension
Doxorubicin 20 mg/10 mL liposomal injectable suspension is a generic prescription medicine for intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
The following individually cartoned vials are available: Table 14 vial…
Key facts
- Active ingredient (INN)
- Doxorubicin
- Brand
- Sold under the generic name
- Strength
- 20 mg/10 mL
- Dosage form
- Liposomal injectable suspension
- Route
- Intravenous
- Packs
- 1 vial of 10 mL and 5 more
- Manufacturers
- Alembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaLupinIndiaBluePoint LaboratoriesBaxter HealthcareQilu Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- The following individually cartoned vials are available: Table 14 vial concentration vial size NDC #s 20 mg/10 mL (2 mg/mL) 10-mL 70748-339-01 50 mg/25 mL (2 mg/mL) 25-mL 70748-340-01 Refrigerate unopened vials of doxorubicin hydrochloride liposome injection at 2°C to 8°C (36°F to 46°F). Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01DB01 Doxorubicin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 August 2019
- Identifiers
- RxCUI 1790115, 1790127DailyMed set ID 0f8eb9a1-74d0-47fd-94b8-a65b29006521, f8e001f5-441c-47cd-86f6-5d5e3de16bc0, c9cb8a8d-944f-4fe1-bfba-c55904a79fda +5NDC 70748-339, 46708-810, 62332-810 +5Application ANDA215178, ANDA219199, NDA050718 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 46708-810-10 | Alembic PharmaceuticalsIndia | 27 June 2025 |
| 1 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 62332-810-10 | Alembic PharmaceuticalsIndia | 27 June 2025 |
| 1 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 75907-363-01 | Dr. Reddy's LaboratoriesIndia | 27 June 2025 |
| 1 vial, single-use in 1 carton / 10 mL in 1 vial, single-use | 70748-339-01 | LupinIndia | 26 August 2024 |
| 1 vial, single-use in 1 carton / 10 mL in 1 vial, single-use | 0338-0080-01 | Baxter Healthcare | 15 August 2019 |
| 1 vial, single-use in 1 carton / 10 mL in 1 vial, single-use | 67184-0623-1 | Qilu Pharmaceutical | 3 February 2026 |
| 1 vial, single-use in 1 carton / 10 mL in 1 vial, single-use | 68001-629-36 | BluePoint Laboratories | 7 January 2025 |
| 1 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 68001-706-36 | BluePoint Laboratories | 5 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Doxorubicin 20 mg/10 mL liposomal injectable suspension.
Other strengths and forms of Doxorubicin
Clinical summary
Doxorubicin is an anthracycline topoisomerase inhibitor indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer, among other approved uses. MedsAcross supplies Doxorubicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxorubicinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxorubicin Hydrochloride prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
- Caelyx pegylated liposomal: European public assessment report (EPAR) · European Medicines Agency
- Myocet liposomal (previously Myocet): European public assessment report (EPAR) · European Medicines Agency
Need Doxorubicin 20 mg/10 mL liposomal injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.